Innovation policy and the economy . 6 [[electronic resource] /] / edited by Adam B. Jaffe, Josh Lerner, and Scott Stern

• Record Nr.: UNINA9910452157803321
• Pubbl/distr/stampa: Cambridge, Mass., : National Bureau of Economic Research, : MIT Press, 2006
• ISBN: 0-262-30891-6; 1-282-09786-5; 9786612097867; 0-262-27619-4; 1-4294-2110-X
• Descrizione fisica: 1 online resource (232 p.)
• Collana: Innovation policy and the economy, , 1531-3468
• Altri autori (Persone): JaffeAdam B; LernerJoshua; SternScott <1969->
• Disciplina: 338.064
• Soggetti: Technological innovations - Government policy - Economic aspects; Diffusion of innovations - Government policy - Economic aspects; Electronic books.
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: Innovation Policy and the Economy: Introduction to Volume 6; 1 Policy Implications of Weak Patent Rights; 2 Innovation and Its Discontents; 3 Consumer Benefi t from Use of the Internet; 4 Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA; 5 Does Globalization of the Scientifi c/Engineering Workforce Threaten U.S. Economic Leadership?; 6 Looking for Mr. Schumpeter: Where Are We in the Competition-Innovation Debate?
• Sommario/riassunto: The economic importance of innovative activity brings with it an active debate on public policy's effect on the innovation process. This annual series, sponsored by the National Bureau of Economic Research, brings the work of leading academic researchers to the broader policy community. Volume 6 considers such topics as the diversity of patent protection and the implications of weak patents for innovation and ; competition; reforms in U.S. patent policy that will encourage innovation; the multifaceted benefits of the Internet for consumers, including price competition and novel forms of communication; the drug development and approval process; the "offshoring" of research and development; and the advantages of industry-specific studies of the relationship between innovation and competition. The papers highlight the role economic theory and empirical analysis can play in evaluating current and prospective innovation policy alternatives.